ALDX 10-Q: SEC filing

Aldeyra Therapeutics

Filed with the SEC on · accession 0001193125-26-449742

ALDX filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Aldeyra Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial statements, equity compensation activity, and fair value measurements. The stock moved -4.9% by the first close after the filing.

Summary of the filing

Aldeyra Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial statements, equity compensation activity, and fair value measurements. The filing also notes a change in the company's principal executive office address to Concord, MA.

Key details

RegistrantAldeyra Therapeutics, Inc.
Option agreement counterpartyAbbVie
Sales agreement counterpartyJefferies

How ALDX stock reacted

Close before

$0.65

Nov 4, 2026

First close after

-4.87%

$0.62

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ALDX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALDX?

Click here

Frequently asked questions

What did ALDX file with the SEC on Nov 5, 2026?

ALDX filed a 10-Q (SEC filing). Aldeyra Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial statements, equity compensation activity, and fair value measurements. The filing also notes a change in the company's principal executive office address to Concord, MA.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ALDX stock react to this filing?

ALDX closed at $0.65 before the filing and $0.62 on Nov 5, 2026 (-4.87%).

Other ALDX SEC filings

Get alerts when ALDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days